Search…

Hong Kong stock pharmaceutical stocks continued to decline, with Tongyu Kang Medicine falling more than 27%.

20/08/2025

As of the deadline for submission, Tongyuan Kang Pharmaceutical fell by 27.23%, Chuangsheng Group-B fell by 8.31%, Cornerstone Pharmaceutical-B fell by 7.41%, Yiming Angke-B fell by 6.71%, and Geli Pharmaceutical-B fell by 5.86%.

Latest

2 m ago

Hong Kong's new consumer stocks surged, with Pop Mart up nearly 12%, Lao Pu Gold up more than 10%, and MUXI Group up more than 5%.

3 m ago

The Hong Kong Stock Exchange announced today that its revenue and profit for the first half of 2025 have both reached a new record high for the half year, with significant strategic progress made in various businesses. The revenue and other income of the Hong Kong Stock Exchange Group in the first half of 2025 amounted to HK$14.076 billion, a year-on-year increase of 33%, while the profit attributable to shareholders reached HK$8.519 billion, a year-on-year increase of 39%.

3 m ago

Hong Kong Exchange: First-half revenue and profits reach record high for first half of the year.

3 m ago

Hong Kong stocks surge | Pop Mart (09992.HK) sees afternoon gains of over 13%, stock price hits historical high again, annual revenue expected to exceed 30 billion yuan

4 m ago

Abnormal movement in Hong Kong stock market | Lao Pu Gold (06181.HK) surged more than 10% in the afternoon, with a 285% year-on-year increase in net profit in the first half of the year and a interim dividend of 9.59 yuan.

See all latest

+852 - 60190728

gmteight@futurecultural.com

Customer Support

Commercial Services